Figure 3.
Dalbavancin concentrations in patients with osteoarticular infections (n = 37) who underwent Cmin-based (upper panel) or Cmax-based (lower panel) therapeutic drug monitoring for dalbavancin concentrations.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.